• Teva Pharmaceutical Industries average return on investment for 2023 was -6.3, a 41.57% decline from 2022.
• Teva Pharmaceutical Industries average return on investment for 2022 was -4.45, a 9% increase from 2021.
• Teva Pharmaceutical Industries average return on investment for 2021 was -4.89, a 16.98% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.